Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revive Therapeutics Ltd
(OP:
RVVTF
)
0.0062
UNCHANGED
Streaming Delayed Price
Updated: 12:16 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revive Therapeutics Ltd
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Psychedelic Stock Gainers And Losers From July 7, 2022
July 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.62% at $0.54
Via
Benzinga
Psychedelic Stock Gainers And Losers From July 6, 2022
July 06, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 20.50% at $0.89
Via
Benzinga
Numinus Wellness, Mind Medicine Among Top Psychedelic Movers Of Today
July 05, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 13.88% at $0.20
Via
Benzinga
Psychedelic Stock Gainers And Losers From July 1, 2022
July 01, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.17% at $0.50
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 30, 2022
June 30, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $10.82
Via
Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
June 29, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.77% at $0.69
Via
Benzinga
Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands
June 29, 2022
Revive Therapeutics Ltd. (OTC: RVVTF) moved closer towards potential endpoint change in their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19.
Via
Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
June 28, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.03% at $0.85
Via
Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
June 27, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 3.12% at $0.82
Via
Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
June 24, 2022
GAINERS: Allied (OTC:ALID) shares closed up 29.44% at $0.56
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
June 23, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 6.63% at $0.71
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 22, 2022
June 22, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 4.17% at $3.50
Via
Benzinga
Revive Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
June 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.43% at $0.31
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 17, 2022
June 17, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.69% at $0.67
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 16, 2022
June 16, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 15, 2022
June 15, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.11% at $0.62
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 14, 2022
June 14, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 9.90% at $9.44
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
June 13, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 1.06% at $0.81 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 10, 2022
June 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
June 09, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
June 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78
Via
Benzinga
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
June 08, 2022
The world of psychedelics is getting a crossover with another category in the millennial catalog of trendy investments: NFTs.
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
June 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72
Via
Benzinga
Revive Therapeutics Moves On Step Closer In COVID Trial By Submitting Data Access Plan To The FDA
June 07, 2022
It was an expected step, but a notable one nonetheless. Revive Therapeutics Ltd.(OTC: RVVTF) revealed they have submitted their Data Access Plan to the U.S. Food & Drug Administration (FDA).
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
June 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36
Via
Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
June 03, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
June 02, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75
Via
Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
June 01, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91
Via
Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36
Via
Benzinga
Revive Therapeutics: Positive Comments From The FDA Regarding Primary Endpoint Change
May 27, 2022
The outlook for Revive Therapeutics Ltd. (OTC: RVVTF) Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19 got a little brighter on Thursday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.